Identity
- Security key
- 13909
- Ticker
- CUE
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2018-01-02
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CUE
Detail
Enriched 2026-08-14 20:47
- Market cap
- $127,774,434.06
- Shares outstanding (class)
- 4,200,343
- Shares outstanding (weighted)
- 4,200,343
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 29
- Location
- BOSTON, MA
- Homepage
- https://www.cuebiopharma.com
- Description
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
Market cap and share counts drift.